Elevation of the opioid precursors pre-proenkephalin and met-enkephalin was found to contribute to the cognitive and behavioral decline in a transgenic mouse model of AD, suggesting the involvement of DOR in AD pathology (Meilandt et al., 2008a). Here, OPRD1 is linked to Alzheimer disease.